{
  "MasterItem": {
    "itemId": "NCLEX_AKI_SAFETY_STOP_001",
    "itemType": "standalone",
    "questionType": "multipleChoice",
    "question": {
      "stem": "A 68-year-old male client with a history of hypertension and type 2 diabetes mellitus is admitted with acute kidney injury (AKI) secondary to dehydration. The nurse is preparing to administer the 0800 medications. Based on the client's electronic health record, which action is most appropriate at this time?",
      "stimulus": [
        {
          "type": "ehrTabs",
          "tabs": [
            {
              "id": "tab1",
              "label": "Nurses' Notes",
              "content": "**0730:** Client admitted to the medical-surgical unit from the emergency department. Alert but lethargic. Reports feeling 'weak and dizzy' for 3 days after an episode of gastroenteritis. States he delayed seeking care because he could not afford to miss work. Mucous membranes are dry, skin turgor is poor. Abdomen soft, non-tender with hypoactive bowel sounds. Bilateral 1+ pitting edema to lower extremities. Oliguria noted since admission. Awaiting morning lab results."
            },
            {
              "id": "tab2",
              "label": "Vital Signs",
              "content": {
                "type": "table",
                "headers": [
                  "Time",
                  "BP",
                  "HR",
                  "RR",
                  "SpO2",
                  "Temp (°C)"
                ],
                "rows": [
                  [
                    "0400 (ED)",
                    "102/64",
                    "98",
                    "20",
                    "97%",
                    "37.1"
                  ],
                  [
                    "0600",
                    "110/68",
                    "92",
                    "18",
                    "98%",
                    "37.0"
                  ],
                  [
                    "0745",
                    "108/66",
                    "84 (Irregular)",
                    "18",
                    "97%",
                    "37.2"
                  ]
                ]
              }
            },
            {
              "id": "tab3",
              "label": "Laboratory Results",
              "content": {
                "type": "table",
                "headers": [
                  "Test",
                  "Result",
                  "Reference Range"
                ],
                "rows": [
                  [
                    "Sodium",
                    "132 mEq/L",
                    "135-145 mEq/L"
                  ],
                  [
                    "Potassium",
                    "7.1 mEq/L",
                    "3.5-5.0 mEq/L"
                  ],
                  [
                    "BUN",
                    "92 mg/dL",
                    "7-20 mg/dL"
                  ],
                  [
                    "Creatinine",
                    "4.8 mg/dL",
                    "0.6-1.2 mg/dL"
                  ],
                  [
                    "eGFR",
                    "14 mL/min/1.73m²",
                    ">60 mL/min/1.73m²"
                  ],
                  [
                    "Troponin T",
                    "<0.01 ng/mL",
                    "<0.04 ng/mL"
                  ]
                ]
              }
            },
            {
              "id": "tab4",
              "label": "Diagnostic Findings",
              "content": "**12-Lead ECG Interpretation (0750):**\nSinus rhythm at 82 bpm with marked peaked T waves, widened QRS complex (0.14 seconds), and prolonged PR interval."
            },
            {
              "id": "tab5",
              "label": "MAR",
              "content": {
                "type": "table",
                "headers": [
                  "Medication",
                  "Dose",
                  "Route",
                  "Frequency",
                  "Time Due"
                ],
                "rows": [
                  [
                    "0.9% NaCl",
                    "100 mL/hr",
                    "IV",
                    "Continuous",
                    "Ongoing"
                  ],
                  [
                    "Lisinopril",
                    "10 mg",
                    "PO",
                    "Daily",
                    "0800"
                  ],
                  [
                    "Metformin",
                    "500 mg",
                    "PO",
                    "BID",
                    "0800"
                  ],
                  [
                    "Ondansetron",
                    "4 mg",
                    "IV",
                    "PRN Q6H",
                    "Available"
                  ]
                ]
              }
            }
          ]
        }
      ],
      "options": [
        {
          "label": "A",
          "content": "Increase the rate of the 0.9% NaCl infusion to 150 mL/hr."
        },
        {
          "label": "B",
          "content": "Administer the scheduled lisinopril and metformin."
        },
        {
          "label": "C",
          "content": "Withhold the lisinopril and immediately notify the healthcare provider."
        },
        {
          "label": "D",
          "content": "Request an order for an IV potassium-wasting diuretic."
        }
      ],
      "correctAnswer": "C"
    },
    "rationale": {
      "correct": "The nurse must analyze all available data to identify the most critical, life-threatening issue. The client has severe AKI (eGFR 14) resulting in critical hyperkalemia (K+ 7.1 mEq/L). The ECG confirms cardiotoxicity from hyperkalemia (peaked T waves, widened QRS). Lisinopril, an ACE inhibitor, is contraindicated because its primary adverse effect is hyperkalemia, which would exacerbate the existing life-threatening condition and could precipitate cardiac arrest. The nurse's immediate, independent priority is to recognize this 'DON'T PROCEED' situation, withhold the harmful medication to prevent iatrogenic injury (non-maleficence), and immediately escalate the critical findings to the provider for emergency intervention.",
      "incorrect": "The incorrect options represent plausible but lower-priority or actively harmful actions that fail to address the immediate life threat.",
      "answerBreakdown": [
        {
          "label": "A",
          "content": "Increasing the IV fluid rate may be appropriate for treating the pre-renal AKI, but the client's blood pressure is stable. This action does not address the immediate, life-threatening cardiotoxicity from severe hyperkalemia, making it a lower priority.",
          "isCorrect": false
        },
        {
          "label": "B",
          "content": "This action is extremely dangerous and constitutes a critical safety error. Administering lisinopril to a client with severe, symptomatic hyperkalemia can lead to fatal cardiac dysrhythmias. Metformin is also contraindicated in severe kidney injury due to the risk of lactic acidosis.",
          "isCorrect": false
        },
        {
          "label": "C",
          "content": "This is the correct 'SAFETY STOP' action. The nurse correctly identifies the critical contraindication and takes the two most important steps: preventing harm by withholding the medication and escalating the life-threatening situation to the provider for definitive treatment (e.g., IV calcium gluconate, insulin/dextrose).",
          "isCorrect": true
        },
        {
          "label": "D",
          "content": "While potassium-wasting diuretics (like furosemide) can treat hyperkalemia, their efficacy is severely diminished in clients with a GFR below 15-20 mL/min. The kidneys are unable to respond. More importantly, this action fails to address the primary safety issue: preventing the administration of a contraindicated medication.",
          "isCorrect": false
        }
      ]
    },
    "pedagogy": {
      "bloomLevel": "Analyzing",
      "cjmmStep": "Take Actions",
      "nclexCategory": "Reduction of Risk Potential",
      "difficulty": "5",
      "topicTags": [
        "Acute Kidney Injury",
        "Hyperkalemia",
        "Medication Safety",
        "ECG Interpretation",
        "Contraindications",
        "ACE Inhibitors",
        "Clinical Judgment"
      ]
    },
    "clinicalPearl": "In patients with AKI and hyperkalemia, always review medications for contraindications, especially ACE inhibitors, ARBs, and potassium-sparing diuretics.  ECG changes (peaked T waves, widened QRS) indicate severe hyperkalemia requiring immediate intervention.  Metformin is contraindicated in AKI due to the risk of lactic acidosis."
  },
  "sentinelStatus": "healed_v2026"
}